Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 11 of 151

  1. AMG 193

    Amgen

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  2. AMG 706

    Takeda

    Advanced Gastrointestinal Stromal Tumor

    phase 2 small molecule completed

    1 trial

  3. AMG 732

    Amgen

    Thyroid Eye Disease

    phase 2 small molecule active

    1 trial

  4. AMG531

    KYOWA KIRIN AUSTRALIA PTY LTD

    Aplastic Anemia

    phase 2 small molecule completed

    1 trial

  5. AMGLIDIA 6 mg/mL oral suspension

    Pari Pharma GmbH

    Transient hyperglycaemia in premature infants

    phase 2 small molecule active

    1 trial

  6. AMINOHIPPURIC ACID for Membranous nephropathy

    Istituto Gentili S.r.l.

    Membranous nephropathy

    phase 2 small molecule active

    1 trial

  7. AML1718

    Fondazione Telethon ETS

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  8. AML2420

    Fondazione Telethon ETS

    Acute Myeloid Leukemia secondary to myeloproliferative neoplasms

    phase 2 small molecule active

    1 trial

  9. AML2521

    Fondazione Telethon ETS

    Acute Myeloid Leukemia with NPM1 mutation

    phase 2 small molecule active

    1 trial

  10. AMT-162-001

    uniQure biopharma B.V.

    Amyotrophic Lateral Sclerosis (ALS)

    phase 2 other active

    1 trial

  11. AMX0035

    Amylyx Pharmaceuticals EMEA B.V.

    ALS

    phase 2 small molecule active

    1 trial

  12. AMX0035

    Amylyx Pharmaceuticals EMEA B.V.

    Wolfram Syndrome

    phase 2 small molecule active

    1 trial

  13. AMX0035

    Amylyx Pharmaceuticals EMEA B.V.

    Alzheimer Disease

    phase 2 small molecule completed

    1 trial

  14. AMY106EU

    Lacuna Pharma Pty Ltd

    Endometriosis

    phase 2 small molecule active

    1 trial

  15. ANAKINRA

    Disc Medicine

    Intracerebral haemorrhage

    phase 2 small molecule active

    1 trial

  16. ANAKINRA

    AXIM BIOTECHNOLOGIES, INC.

    Hyperinflammation, Sepsis

    phase 2 small molecule active

    1 trial

  17. ANEB-001

    Anebulo Pharmaceuticals

    Acute Cannabinoid Intoxication

    phase 2 small molecule completed

    1 trial

  18. ANN-008

    Lacuna Pharma Pty Ltd

    Diabetic Retinopathy, Retinal Vein Occlusion

    phase 2 other active

    1 trial

  19. AP-PA02

    Armata Pharmaceuticals

    Non-cystic Fibrosis Bronchiectasis

    phase 2 mab completed

    1 trial

  20. AP-PA02

    Armata Pharmaceuticals

    Cystic Fibrosis

    phase 2 mab completed

    1 trial

  21. AP-SA02

    Armata Pharmaceuticals

    Bacteremia

    phase 2 mab completed

    1 trial

  22. AP-recAP-CSA-RD-0201

    Lacuna Pharma Pty Ltd

    Risk for renal damage following open heart surgery

    phase 2 small molecule active

    1 trial

  23. AP01-007

    Lacuna Pharma Pty Ltd

    Progressive Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  24. AP01-201

    Lacuna Pharma Pty Ltd

    Acute Heart Failure

    phase 2 small molecule active

    1 trial

  25. AP02-003

    Lacuna Pharma Pty Ltd

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 2 small molecule active

    1 trial

  26. AP101-02

    Lacuna Pharma Pty Ltd

    Amyotrophic Lateral Sclerosis (ALS)

    phase 2 small molecule active

    1 trial

  27. AP24534-14-203

    Takeda

    Chronic Phase Chronic Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  28. AP31969-M201

    Lacuna Pharma Pty Ltd

    Atrial fibrillation

    phase 2 small molecule active

    1 trial

  29. AP707, Placebo

    Lacuna Pharma Pty Ltd

    Borderline personality disorder

    phase 2 small molecule active

    1 trial

  30. APD334

    Arena Pharmaceutical Enterprises Limited

    Primary Biliary Cholangitis

    phase 2 small molecule terminated

    1 trial

  31. APD334

    Arena Pharmaceutical Enterprises Limited

    Pyoderma Gangrenosum

    phase 2 small molecule terminated

    1 trial

  32. APD811

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule completed

    1 trial

  33. APG-2575CU101

    Lacuna Pharma Pty Ltd

    Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

    phase 2 small molecule active

    1 trial

  34. APG777

    Apogee Therapeutics

    Atopic Dermatitis

    phase 2 small molecule active

    3 trials

  35. APG777, Placebo

    Apogee Therapeutics

    Atopic Dermatitis

    phase 2 small molecule active

    1 trial

  36. APHP 180672

    Pari Pharma GmbH

    acute osteomyelitis of the child

    phase 2 small molecule active

    1 trial

  37. APHP 240614

    Pari Pharma GmbH

    TAkayasu ARteritiS

    phase 2 small molecule active

    1 trial

  38. APHP180351

    Pari Pharma GmbH

    Cryoglobulinemia vasculitis

    phase 2 small molecule active

    1 trial

  39. APHP180572

    Pari Pharma GmbH

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  40. APHP190131

    Pari Pharma GmbH

    Primary Sjogren's syndrome

    phase 2 small molecule active

    1 trial

  41. APHP190205

    Pari Pharma GmbH

    PRIMARY PLASMA CELL LEUKEMIA: A PROSPECTIVE PHASE II STUDY INCORPORATING DARATUMUMAB TO CHEMOTHERAPY AND STEM CELL TRANSPLANTATION

    phase 2 small molecule active

    1 trial

  42. APHP190648

    Pari Pharma GmbH

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  43. APHP200007

    Pari Pharma GmbH

    Severe uveitis of Behçet’s disease

    phase 2 small molecule active

    1 trial

  44. APHP200041

    Pari Pharma GmbH

    Newly diagnosed or relapsing Giant-cell arteritis

    phase 2 small molecule active

    1 trial

  45. APHP200042

    Pari Pharma GmbH

    Patients treated with lithium carbonate for a bipolar disorder treated for at least 5 years and with a urine concentration defect.

    phase 2 small molecule active

    1 trial

  46. APHP200080

    Pari Pharma GmbH

    Newly diagnosed Glioblastoma (IDH wild-type) patients at initial radiological diagnosis eligible for tumor resection, and for the standard of care including concurrent temoradiation followed by adjuvant TMZ with or without Tumor Treating Fields*. (*Tumor Treating Fields is applicable only in participating centers in France)

    phase 2 small molecule active

    1 trial

  47. APHP200132

    Pari Pharma GmbH

    children, adolescents and young adults with Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  48. APHP200133

    Pari Pharma GmbH

    Melanoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.